BACCARANI, Umberto
 Distribuzione geografica
Continente #
NA - Nord America 18.087
EU - Europa 5.129
AS - Asia 1.968
AF - Africa 30
Continente sconosciuto - Info sul continente non disponibili 20
OC - Oceania 3
SA - Sud America 3
Totale 25.240
Nazione #
US - Stati Uniti d'America 17.982
UA - Ucraina 1.652
DE - Germania 1.212
CN - Cina 903
IT - Italia 768
SG - Singapore 652
FI - Finlandia 540
IE - Irlanda 316
RU - Federazione Russa 238
TR - Turchia 178
SE - Svezia 169
CA - Canada 99
GB - Regno Unito 79
VN - Vietnam 70
IN - India 65
IR - Iran 52
FR - Francia 47
BE - Belgio 31
CZ - Repubblica Ceca 24
EU - Europa 20
HK - Hong Kong 13
TG - Togo 11
KR - Corea 10
NL - Olanda 10
AT - Austria 8
EG - Egitto 8
TW - Taiwan 8
KE - Kenya 7
PL - Polonia 7
LT - Lituania 4
PA - Panama 4
AU - Australia 3
CH - Svizzera 3
ES - Italia 3
RO - Romania 3
AE - Emirati Arabi Uniti 2
BG - Bulgaria 2
BR - Brasile 2
EE - Estonia 2
HR - Croazia 2
IL - Israele 2
JP - Giappone 2
LA - Repubblica Popolare Democratica del Laos 2
LI - Liechtenstein 2
MA - Marocco 2
MD - Moldavia 2
NO - Norvegia 2
TH - Thailandia 2
ZA - Sudafrica 2
AL - Albania 1
AZ - Azerbaigian 1
CL - Cile 1
CY - Cipro 1
DK - Danimarca 1
GE - Georgia 1
IQ - Iraq 1
JM - Giamaica 1
MX - Messico 1
MY - Malesia 1
PH - Filippine 1
PK - Pakistan 1
RS - Serbia 1
Totale 25.240
Città #
Fairfield 2.735
Woodbridge 1.814
Ashburn 1.304
Houston 1.291
Jacksonville 1.164
Chandler 1.137
Wilmington 1.075
Seattle 1.044
Cambridge 977
Ann Arbor 924
Dearborn 760
Singapore 555
Udine 475
Boardman 392
Beijing 386
Princeton 329
Dublin 316
Izmir 171
San Diego 151
Hefei 77
Ogden 76
Dong Ket 69
Ottawa 69
Norwalk 56
Des Moines 53
Nanjing 50
Kunming 47
Helsinki 36
Los Angeles 34
Brussels 31
New York 31
Washington 27
Guangzhou 26
Redmond 25
Jinan 23
Milan 23
Leawood 22
Nanchang 21
Augusta 20
Grafing 19
Munich 19
Toronto 19
Ardabil 18
Monmouth Junction 17
Brno 16
Chengdu 16
Pune 16
San Mateo 16
Fuzhou 15
Shanghai 15
Trieste 15
Rome 14
Hong Kong 13
Zanjan 13
Dallas 12
Hyderabad 12
Simi Valley 12
Lomé 11
Phoenix 11
Santa Clara 11
Zhengzhou 10
London 9
Ningbo 9
Redwood City 8
Shenyang 8
Shenzhen 8
Wuhan 8
Hebei 7
Nairobi 7
Olomouc 7
Taipei 7
Xian 7
Auburn Hills 6
Changsha 6
Saint Petersburg 6
Shaoxing 6
Andover 5
Bologna 5
Latisana 5
Moscow 5
Murano 5
Sacramento 5
Xiamen 5
Baotou 4
Cairo 4
Chongqing 4
Clifton 4
Indiana 4
Taizhou 4
Tianjin 4
Vancouver 4
Venezia 4
Vienna 4
Charlotte 3
Columbus 3
Fano 3
Frankfurt am Main 3
Hangzhou 3
Harbin 3
Henderson 3
Totale 18.341
Nome #
Extended Ureteral Stricture Corrected with Appendiceal Replacement in a Kidney Transplant Recipient 230
In vitro functional assessment of a porcine hepatocytes based bioartificial liver 189
LONG-TERM OUTCOMES OF ORTHOTOPIC LIVER TRANSPLANTATION IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS AND COMPARISON WITH HUMAN IMMUNODEFICIENCY VIRUS-NEGATIVE CASES 166
Steatosis of the graft is a risk factor for posttransplantation biliary complications. 165
Hepatitis B-core antibody positive donors in liver transplantation and their impact on graft survival: Evidence from the Liver Match cohort study 161
Improved survival in liver transplant recipients receiving prolonged-release tacrolimus in the European liver transplant registry 156
Balancing donor and recipient risk factors in liver transplantation: the value of D-MELD with particular reference to HCV recipients. 155
A single-center experience of late retransplantation of the liver. 149
A comparative prospective study of two available solutions for kidney and liver preservation 146
Laparoscopic sleeve gastrectomy as a weight reduction strategy in obese patients after kidney transplantation 145
Liver Match, a prospective observational cohort study on liver transplantation in Italy: study design and current practice of donor-recipient matching 136
La splenectomia laparotomica e laparoscopica 136
Fifteen years and 382 extended right grafts from in situ split livers in a multicenter study: Are these still extended criteria liver grafts? 134
A Matched Pair Analysis of Multicenter Long-term Follow-up after Split Liver Transplantation with Extended Right Grafts 134
Impact of surgical complications on the risk of hepatocellular carcinoma recurrence after hepatic resection 134
Splenic Artery Syndrome as a Possible Cause of Late Onset Refractory Ascites after Liver Transplantation: Management with Proximal Splenic Artery Embolization 133
Differential proteomic analysis of hepatocellular carcinoma 131
Impact of new treatment options for hepatitis c virus infection in liver transplantation 131
Laparoscopic treatment of symptomatic lymphoceles after kidney transplantation 130
Diaphragm rupture in a liver transplant patient under chronic immunosuppressive therapy with sirolimus: rare complication after liver transplantation 129
Liver transplantation from old donors into HCV and non-HCV recipients 129
Postsplenectomy recurrence of idiopathic thrombocitopenic purpura: role of laparoscopic splenectomy in the treatment of accessory spleen 129
Ileocecal Fistula Caused by Multiple Foreign Magnetic Bodies Ingestion 129
Antiretroviral blood levels in HIV/HCV-coinfected patients with cirrhosis after liver transplant: A report of three cases 126
Donor safety in living donor liver donation: An Italian multicenter survey 125
Development of Small Bowel Volvulus on Barbed V-Loc™ Suture: A Rare Complication after Laparoscopic Ventral Rectopexy 125
BENEFIT OF LAPAROSCOPY FOR RECTAL RESECTION IN PATIENTS OPERATED SIMULTANEOUSLY FOR SYNCHRONOUS LIVER METASTASES: PRELIMINARY EXPERIENCE. 122
Detection of transplant renal artery stenosis with contrast-enhanced ultrasound 122
Transarterial chemoembolization does not harm the hepatic artery at transplantation 121
DE NOVO TUMORS ARE A MAJOR CAUSE OF LATE MORTALITY AFTER ORTHOTOPIC LIVER TRANSPLANTATION 120
Isolation of Human Hepatocytes from Livers Rejected for Liver Transplantation on a National Basis: Results of a 2 Year-Experience 120
Transesophageal echocardiography in orthotopic liver transplantation: a comprehensive intraoperative monitoring tool 120
Safety of conversion from twice-daily tacrolimus (Prograf) to once-daily prolonged-release tacrolimus (Advagraf) in stable liver transplant recipients 119
Future of minimally invasive surgery 118
Liver Retransplantation in Patients with HIV-1 Infection: An International Multicenter Cohort Study 118
De Novo Solid Tumors after Kidney Transplantation: Is It Time for a Patient-Tailored Risk Assessment? Experience from a Single Center 116
Sequential versus contemporaneous portal and arterial reperfusion during liver transplantation. 116
Safety and efficacy of splenic artery embolization for portal hyperperfusion in liver transplant recipients: A 5-year experience 116
Predictors of endoscopic treatment outcome in the management of biliary complications after orthotopic liver transplantation 115
RENAL ALLOGRAFT PROTECTION WITH EARLY ANGIOTENSIN-CONVERTING ENZYME INHIBITORS ADMINISTRATION 115
Single-time kidney transplantation and monolateral nephrectomy for hypertension and antihypertensive therapy in renal transplant recipients 115
Quality-of-life assessment before and after liver transplantation. 114
Complete Remission of Unresectable Hepatocellular Carcinoma after Combined Sorafenib and Adjuvant Yttrium-90 Radioembolization 114
Treatment of Candida Infections with Fluconazole in Adult Liver Transplant Recipients: Is TDM-guided Dosing Adaptation Helpful? 114
Biliary penetration and pharmacodynamic exposure of linezolid in liver transplant patients 113
Biliary pharmacodynamic exposure to linezolid in two liver transplant patients. 113
Steatotic versus cirrhotic livers as a source for human hepatocyte isolation 113
Hyperlactacidemia Potentially Due to Linezolid Overexposure in a Liver Transplant Recipient 112
Pharmacokinetic Profile of Prolonged-Release Tacrolimus When Administered via Nasogastric Tube in De Novo Liver Transplantation: A Sub-Study of the DIAMOND Trial 112
Intra-abdominal penetration and pharmacodynamic exposure to fluconazole in three liver transplant patients with deep-seated candidiasis 112
Cryopreserved human hepatocytes from cell bank: In vitro function and clinical application 111
Portal vein thrombosis after intraportal hepatocytes transplantation in a liver transplant recipient 111
Acute pancreatitis after kidney transplantation. 110
HIV-INFECTED PATIENTS AND LIVER TRANSPLANTATION: WHO, WHEN AND WHY 109
TREATMENT OF RECURRENT SYMPTOMATIC LYMPHOCELE AFTER KIDNEY TRANSPLANTATION WITH INTRAPERITONEAL TENCKHOFF CATHETER 109
De novo malignancies after liver and kidney transplantations: A single center experience on 582 consecutive cases. 108
STEATOSIS OF THE HEPATIC GRAFT AS A RISK FACTOR FOR POST-TRANSPLANT BILIARY COMPLICATIONS 108
De novo malignancies after kidney and liver transplantations: experience on 582 consecutive cases. 108
Comparison of clinical and pathological staging and long-term results of liver transplantation for hepatocellular carcinoma in a single transplant center 107
Arterial rupture as the result of fungal arteritis after renal transplantation 107
null 107
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. 106
DE NOVO GASTROINTESTINAL TUMOURS AFTER RENAL TRANSPLANTATION: ROLE OF CMV AND EBV VIRUSES 106
COMBINED APPROACH FOR SPONTANEOUS RUPTURE OF HEPATOCELLULAR CARCINOMA 105
Technical solutions for venous outflow reconstruction in damaged liver grafts during procurement: Case reports 105
APURINIC APYRIMIDINIC ENDONUCLEASE/REDOX EFFECTOR FACTOR 1 IMMUNOREACTIVITY AND GRADING IN HEPATOCELLULAR CARCINOMA RISK OF RELAPSE AFTER LIVER TRANSPLANTATION 105
A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list. 105
Overoxidation of peroxiredoxins as an immediate and sensitive marker of oxidative stress in HepG2 cells and its application to the redox effects induced by ischemia/reperfusion in human liver 105
MeltDose Technology vs Once-Daily Prolonged Release Tacrolimus in De Novo Liver Transplant Recipients 104
Hepatocyte isolation using human livers discarded from transplantation: Analysis of cell yield and function 103
Successful minimally invasive management of late portal vein thrombosis after splenectomy due to splenic artery steal syndrome following liver transplantation: a case report 103
OCCULT HEPATITIS B VIRUS INFECTION IN LIVER TRANSPLANT RECIPIENTS WITH RECURRENT HEPATITIS C: RELATIONSHIP WITH DONOR AGE AND FIBROSIS PROGRESSION 103
Head and neck and esophageal cancers after liver transplant: Results from a multicenter cohort study. Italy, 1997-2010 103
Angiotensin-converting enzyme inhibitors reduce hemoglobin concentrations, hematocrit, and serum erythropoietin levels in renal transplant recipients without posttransplant erythrocytosis 102
Transient ischemic attack after rizatriptan administration in a liver transplant recipient: A case report 102
CARDIOVASCULAR RISK FACTORS AND IMMUNOSUPPRESSIVE REGIMEN AFTER LIVER TRANSPLANTATION 102
Current preventive strategies and management of Epstein-Barr virus-related post-transplant lymphoproliferative disease in solid organ transplantation in Europe. Results of the ESGICH Questionnaire-based Cross-sectional Survey 102
Risk of virus and non-virus related malignancies following immunosuppression in a cohort of liver transplant recipients. Italy, 1985–2014 102
Early post-liver transplant surgical morbidity in HIV infected recipients: risk factor for overall survival? A nationwide retrospective study 102
Split and whole liver transplantation outcomes: A comparative cohort study 101
Multipotent cells can be generated in vitro from several adult human organs (heart, liver and bone marrow) 101
Steatosis of the hepatic graft as a risk factor for post-transplant biliary complications 101
. Quantification of human livers as an effective source of hepatocytes for clinical application 100
Long-term placement of subcutaneous Rusch-type stents for double biliary stenosis in a living-donor liver transplant recipient 100
Role of cytomegalovirus and Epstein-Barr virus in patients with de novo colon cancer after renal transplantation. 100
Liberase HI enzyme versus collagenase type P for porcine hepatocyte isolation 100
Surgical staging in Hodgkin's disease: the role of laparoscopic splenectomy 100
IMMUNESUPPRESSION AND CANCER: A COMPARISON OF RISKS IN RECIPIENTS OF ORGAN TRANSPLANTS AND HIV-POSITIVE INDIVIDUALS 100
Selective bilirubin Removal by Plasma Treatment With Plasorba BR-350 for Early Cholestatic Graft Dysfunction 99
Liver resection for hepatocellular carcinoma: A multivariate analysis of factors associated with improved prognosis. The role of clinical, pathological and surgical related factors 99
Pharmacokinetic drug interaction between everolimus and antifungal triazoles in a liver transplant patient 99
Non-erosive and uncomplicated erosive reflux diseases: Difference in physiopathological and symptom pattern. 99
Liver Transplant in Patients with HIV: Infection Risk Associated with HIV and Post-transplant Immunosuppression 99
Laparoscopic versus open splenectomy in the management of splenomegaly: our preliminary experience 98
Graft vessel wall pathology in a case of hepatic artery pseudo-aneurysm in a liver transplant recipient 98
Appendicectomy and Crohn's disease: clinical and genetic associations 98
Perioperative intra- and extravascular volume in liver transplant recipients. 98
Tacrolimus Therapeutic Drug Monitoring in Stable Kidney Transplantation and Individuation of CYP3A5 Genotype 98
Pros and cons of liver transplantation in human immunodeficiency virus infected recipients 97
A Simple Trick for Optimizing the Three-Vein Technique Outflow Anastomosis in Piggyback Liver Transplantation 96
Totale 11.684
Categoria #
all - tutte 97.138
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 97.138


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.683 0 0 0 0 0 0 925 864 592 623 237 442
2020/20214.354 117 473 138 472 284 505 315 534 593 170 515 238
2021/20222.537 109 280 73 128 36 97 168 139 34 472 604 397
2022/20232.588 358 212 41 335 233 701 6 170 337 30 70 95
2023/2024957 115 89 43 26 162 152 12 81 138 55 18 66
2024/20251.551 140 402 202 236 264 304 3 0 0 0 0 0
Totale 25.739